Helmholtz Munich, United States
Disclosure information not submitted.
Biomimetic-scaffolds recapitulating native microarchitecture improved long-term survival and function of stem-cell-derived β-cells transplanted in subcutaneous space for treating type1 diabetes
Thursday, October 9, 20252:00 PM - 2:15 PM PDT
